Dr. Malcolm Brenner was recently named a member of the National Academy of Medicine, a prestigious panel of doctors that advises federal officials on health issues. Brenner is the director of the Center for Cell and Gene Therapy at Baylor College of Medicine, which is responsible for stem cell transplant programs at Texas Children’s and Methodist hospitals.
As a clinician-scientist, Brenner has pioneered basic and clinical research focused on use of gene transfer to augment the immune response to tumors. His contributions have led to the development of genetically modified T cells that can safely and effectively target cancer tumors.
Brenner has received many awards for his work including the American Society for Gene and Cell Therapy Outstanding Achievement, the American Society of Hematology Mentor Award and the Pioneer Award from the peer-reviewed journal Human Gene Therapy in recognition of his scientific achievements and leadership in the field.
This honor from the National Academy of Medicine was bestowed to Brenner during the academy’s annual conference on October 17.